Back to Search Start Over

639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy

639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy

Details

Database :
OpenAIRE
Journal :
Regular and Young Investigator Award Abstracts
Accession number :
edsair.doi...........f6ae07ed46986b05129836d4c3d8ddad
Full Text :
https://doi.org/10.1136/jitc-2022-sitc2022.0639